Olaplex Reports Slight Increase in Net Sales but Faces Net Loss for Fiscal Year 2025

Olaplex Holdings, Inc. reported a slight increase in net sales for the fiscal year ended December 31, 2025, totaling $422.96 million, compared to $422.67 million in 2024. This represents a marginal growth of 0.1%. The company's professional and direct-to-consumer (DTC) channels saw increases of 5.5% and 3.1%, respectively, while specialty retail sales declined by 8.3%. The geographic distribution of sales remained balanced, with 48% of net sales generated in the U.S. and 52% internationally, reflecting a shift from the previous year when both markets contributed equally.

Despite the increase in sales, Olaplex reported a net loss of $9.25 million for 2025, a significant decline from a net income of $19.52 million in 2024. This downturn was attributed to a substantial rise in operating expenses, which increased by 27.2% to $286.70 million, primarily driven by higher marketing costs, legal fees, and acquisition-related expenses. The company's gross profit margin slightly improved to 69.4%, up from 69.2% in the prior year, due to a decrease in the cost of sales, which fell to $129.31 million from $130.38 million.

Strategically, Olaplex made notable advancements, including the acquisition of Purvala Bioscience, Inc. for $10.5 million, aimed at enhancing its innovation capabilities. The company also focused on expanding its product portfolio, launching new items such as the No. 4FINE and No. 5FINE Bond Maintenance® Shampoo and Conditioner, and the No. 0.5 Scalp Longevity Treatment. These initiatives are part of Olaplex's broader strategy to leverage its proprietary bond-building technology and address diverse consumer needs in the haircare market.

Operationally, Olaplex employed 278 individuals as of December 31, 2025, and maintained a flexible supply chain, with a significant portion of its products manufactured by Cosway Company Inc., which accounted for 54% of net sales. The company also reported a liquidity position of $468.7 million, bolstered by $318.7 million in cash and cash equivalents and $150 million in available borrowing capacity under its revolving credit facility. Looking ahead, Olaplex anticipates continued growth driven by its innovation strategy and market expansion efforts, despite facing challenges from competitive pressures and economic conditions.